language
English
العربية
বাংলাদেশ
Български
Hrvatski
Česky
Dansk
Nederland
Esperanto
Slovenski
filipino
Suomi
Français
Maori
Georgian
Deutsch
Ελλάδα
ישראל
इंडिया
Magyarország
Ísland
Indonesia
Irlanda
Italia
日本語
Sovensko
Հայաստան
한국
Kyrgyz
ປະເທດລາວ
Latvian
Lithuanian
Luxembourgish
Macedonian
Малайская
Maltese
Монгол улс
ဗမာ
नेपाल
Norge
ایران
Polska
Portugal
România
Российская
Србија
Србија
Bosanski
Slovenian
Беларус
España
Sverige
Точик
ประเทศไทย
Türk
Azərbaycan
Uzbek
Việt Nam
FDA Guidelines for Skin Care Packaging: What Every Brand Must Follow
Mar 19,2026



FDA Guidelines for Skin Care Packaging: What Every Brand Must Follow
In the United States, the Food and Drug Administration (FDA) regulates skincare packaging under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and related regulations. While the FDA does not “approve” cosmetics packaging in the same way it approves drugs, it imposes strict requirements to ensure packaging is safe, sanitary, and accurately labeled. Non-compliance can result in warning letters, product seizures, or even criminal charges.
A 2024 FDA enforcement report revealed that 27% of cosmetic packaging violations were related to misleading claims, 22% involved material safety issues, and 18% stemmed from inadequate labeling. For brands—especially startups—understanding and following FDA guidelines is critical to launching safely and maintaining market access.
This guide breaks down the key FDA requirements for skincare packaging, covering material safety, labeling rules, prohibited substances, and best practices for compliance.
1. Material Safety: Ensuring Packaging Doesn’t Contaminate Products
The FDA considers packaging an “indirect food additive” when it contacts skincare products (which are regulated as cosmetics). This means packaging materials must not transfer harmful substances to the product under normal use conditions.
Key Regulations
21 CFR Part 177: Lists acceptable materials for food and cosmetic contact, including plastics (e.g., PET, HDPE, PP), glass, metals (e.g., aluminum, stainless steel), and paperboard.
21 CFR Part 175: Covers adhesives, coatings, and inks used in packaging. These must not migrate into the product in unsafe amounts.
Prohibited Materials
The FDA bans or restricts:
PVC (Polyvinyl Chloride): Contains phthalates, which are endocrine-disrupting chemicals (EDCs) and potential carcinogens.
Polycarbonate (PC): Leaches bisphenol A (BPA), linked to hormonal disruption.
Lead and Cadmium: Heavy metals that can migrate from colored inks or metal closures.
Formaldehyde-Releasing Agents: Used in some adhesives or coatings; classified as a probable human carcinogen.
Best Practices
Use FDA-Compliant Materials: Request a Certificate of Compliance (CoC) from suppliers confirming materials meet 21 CFR standards.
Avoid Recycled Materials Without Testing: Recycled plastics may contain contaminants; ensure they are reprocessed to remove impurities.
Conduct Migration Testing: Simulate product contact over time to verify no harmful substances leach into the formula.
2. Labeling Requirements: Truthful, Legible, and Comprehensive
FDA labeling rules (21 CFR Parts 701 and 740) govern what must appear on skincare packaging, where, and how.
Required Label Elements
Principal Display Panel (PDP)
Identity Statement: The product’s common or usual name (e.g., “Hydrating Face Cream”).
Net Quantity: Metric and U.S. customary units (e.g., “50 ml / 1.7 fl oz”).
Brand Name: Prominently displayed.
Information Panel
Ingredient List: INCI (International Nomenclature of Cosmetic Ingredients) names in descending order by concentration.
Exception: Trade secrets (e.g., proprietary fragrances) may be listed as “Fragrance (Parfum)” if disclosed to the FDA.
Name and Address: Manufacturer, packer, or distributor (including street address, city, state, and ZIP code).
Warnings: Required for products posing risks (e.g., “For external use only,” “Avoid contact with eyes”).
Directions for Use: Clear instructions (e.g., “Apply twice daily to clean skin”).
Additional Requirements
Legibility: Text must be at least 1/16 inch (1.6 mm) in height for most labels; smaller text allowed for secondary panels.
Language: All mandatory information must be in English.
Accuracy: No false or misleading claims (e.g., “FDA-approved” for a cosmetic, which is illegal).
Common Labeling Violations
Omitting Net Quantity: A frequent FDA citation, especially for travel-sized products.
Incorrect INCI Names: Using trade names instead of standardized INCI identifiers (e.g., “Vitamin C” instead of “Ascorbic Acid”).
Unsubstantiated Claims: “Anti-aging,” “hypoallergenic,” or “dermatologist-tested” require supporting data.
3. Prohibited and Restricted Substances in Packaging
The FDA prohibits certain substances in packaging materials, either outright or with restrictions:
Substance | Regulation | Reason |
|---|---|---|
Phthalates | 21 CFR 175.105 | Endocrine disruption, reproductive harm |
BPA | Indirect food additive ban | Hormonal effects, developmental toxicity |
Lead | 21 CFR 175.300 | Neurotoxicity, organ damage |
Formaldehyde | 21 CFR 177.2600 | Carcinogenicity, skin sensitization |
PFAS (Perfluoroalkyls) | Emerging concern | Environmental persistence, health risks |
How to Ensure Compliance
Request Material Safety Data Sheets (MSDS): From suppliers to verify absence of restricted substances.
Third-Party Testing: Use labs accredited by ISO/IEC 17025 to test for migration of heavy metals, phthalates, or BPA.
Avoid “Greenwashing” Claims: Don’t label packaging as “BPA-free” or “non-toxic” unless verified by testing.
4. Good Manufacturing Practices (GMP) for Packaging
The FDA’s GMP guidelines (21 CFR Part 700) require packaging processes to be sanitary and consistent:
Facility Requirements
Cleanliness: Packaging areas must be free from pests, dust, and contaminants.
Equipment Maintenance: Regular calibration and cleaning to prevent cross-contamination.
Employee Hygiene: Staff handling packaging must follow hygiene protocols (e.g., gloves, hairnets).
Documentation
Batch Records: Track packaging materials, production dates, and quality checks.
Change Control: Document any changes to packaging suppliers, materials, or processes.
Recall Procedures: Have a plan to remove defective packaging from the market.
5. Advertising and Promotional Materials
While not strictly “packaging,” promotional materials (e.g., product inserts, website ads) must comply with FDA rules:
No Drug Claims: Cosmetics cannot claim to treat or prevent disease (e.g., “cures eczema”).
Truthful Claims: Substantiate all performance claims (e.g., “hydrates for 24 hours” requires testing).
Fair Balance: Avoid exaggeration or misleading imagery (e.g., showing dramatic before/after results without proof).
6. Recent FDA Enforcement Trends
The FDA has increased scrutiny on:
PFAS in Packaging: Issued warning letters to brands using PFAS-containing paperboard or coatings.
Online Sales: Monitoring e-commerce listings for misleading packaging claims (e.g., “FDA-approved” on Amazon).
Imported Packaging: Rejecting shipments with non-compliant materials or labeling.
7. How to Achieve and Maintain Compliance
Step 1: Conduct a Packaging Audit
Review all materials, labels, and suppliers against FDA regulations.
Step 2: Partner with FDA-Experienced Suppliers
Choose vendors familiar with 21 CFR requirements and able to provide CoCs.
Step 3: Test Rigorously
Perform migration testing, material safety analysis, and label legibility checks.
Step 4: Stay Updated
Subscribe to the FDA’s email alerts and attend industry webinars (e.g., Society of Cosmetic Chemists events).
Case Studies: FDA Actions Against Non-Compliant Packaging
1. Phthalate-Containing Droppers
In 2023, the FDA issued a warning letter to a skincare brand using PVC droppers in its vitamin C serum. Testing showed phthalate migration exceeding safe limits. The brand recalled products and switched to silicone-sealed glass droppers.
2. Misleading “FDA-Approved” Claims
A startup marketed its night cream as “FDA-approved for sensitive skin.” The FDA deemed this false advertising, as cosmetics are not subject to pre-market approval. The company faced fines and was forced to remove the claim from all packaging and ads.
Conclusion: Compliance as a Foundation of Trust
FDA guidelines for skincare packaging are not just legal hurdles—they are a framework for ensuring consumer safety and brand integrity. By prioritizing material safety, accurate labeling, and sanitary manufacturing, you protect both your customers and your business.
In an industry where trust is everything, FDA compliance is your first step toward building a reputable, resilient brand.
Ready to ensure your packaging meets FDA standards? Download our FDA Packaging Compliance Checklistto guide your audits, testing, and supplier partnerships.